Report Categories
View AllRecent Articles
View All
The key driver behind CreditAccept CACC revenue growth Q1 2026 Profit Disappoints
Why Neumora Therapeutics NMRA might be the steady performer you need Technical Strength 20260506
LUCY Innovative Eyewear posts far narrower Q4 2025 loss than consensus estimates even as shares slip modestly
ECAT BlackRock shares updated ESG capital allocation plans alongside its latest quarterly earnings results
Sothebys Thwarts Attempt to Sell Counterfeit Ancient Artifacts Fraud Case Highlights Due Diligence in Art Market
Wall Streets Rally May Face Headwinds as Earnings Season Concludes and Bond Yields Rise
Inflation Pressures Widen Beyond Oil and Iran Other Sectors Show Reacceleration
Pudu Robotics Founder Felix Zhang Highlights Global Expansion and One Brain Multiple Embodiments Strategy at BEYOND Expo 2026
Gold Futures Rise to 159 Lakh10g Amid Weak Dollar and USIran Peace Deal Prospects
SK Hynix Joins TrillionDollar Valuation Club on AIDriven Chip Demand Surge
LGL Q1 2026 Earnings Loss Per Share Disappoints Amid Missing Revenue Data
DMLP Q4 2024 Earnings EPS of 024 Reported Amid Commodity Price Fluctuations
ACRE Q1 2026 Earnings Deeper Than Expected Loss Despite Positive Stock Reaction
CPSH Q1 2026 Earnings Loss Per Share Misses Estimates Broadly as Stock Rises
BVN Q4 2025 Earnings Massive EPS Beat of 122 Driven by Strong Operational Performance
IRON Q1 2026 Earnings Narrower Loss Beats Estimates as Disc Medicine Advances Clinical Pipeline
Haymaker Acquisition Corp 4 HYAC Edges Higher Above 1075 as SPAC Gains Momentum
MUZE Holds Steady Near Midpoint of Range
Crescent Capital BDC CCAP Edges Higher as Support Holds Near 1088
Evaxion EVAX Holds Steady Near Support Amid Low Volume Consolidation
BOK Financial BOKF Edges Higher Testing Resistance Near 139 After Modest Gain
NXST Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance
SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment
MOMO Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines
Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress
AGNCZ Q1 2026 Earnings Preferred EPS Surpasses Estimates by 145
III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher